Spironolactone Tablet
Product Images NDC 64980-706

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 64980-706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (198e8618 C012 4f1c 9365 84c1829893c0 01)

Chemical structure of spironolactone, showing its steroid backbone with attached functional groups including methyl, ketone, and thioacetate substituents.*

FDA Label Image

Image (198e8618 C012 4f1c 9365 84c1829893c0 02)

A Kaplan-Meier survival curve comparing Spironolactone and placebo over a period of approximately 48 months. The y-axis represents probability, and the x-axis represents months. The chart includes two lines for Spironolactone and placebo groups, with a reported log-rank p-value less than 0.001 indicating statistical significance.*

FDA Label Image

Image (198e8618 C012 4f1c 9365 84c1829893c0 03)

A forest plot chart showing hazard ratios (HR) and 95% confidence intervals (CI) across various subgroups for Spironolactone versus placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium level, digoxin use, ACEI use, and beta blocker use. The plot visually compares Spironolactone effectiveness against placebo.*

FDA Label Image

25 mg 30's (198e8618 C012 4f1c 9365 84c1829893c0 04)

Spironolactone Tablets, USP 25 mg oral tablets packaging label. The label shows the product name, strength, 100 tablet count, and indicates prescription use (Rx only). It is labeled by Rising Pharma Holdings, Inc. and manufactured by Graviti Pharmaceuticals Pvt. Ltd., India. Storage instructions and a barcode are also visible.*

FDA Label Image

50mg 30's (198e8618 C012 4f1c 9365 84c1829893c0 05)

Label for Spironolactone Tablets USP 50 mg, oral tablets, containing 100 tablets per package. The label shows the product is manufactured by Graviti Pharmaceuticals Pvt. Ltd. in India and distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ. Storage instructions and dispensing requirements are noted, along with a barcode.*

FDA Label Image

100mg 30's (198e8618 C012 4f1c 9365 84c1829893c0 06)

Label for Spironolactone Tablets, USP 100 mg oral tablets by Rising Pharma Holdings, Inc. The label indicates a package count of 100 tablets. Manufactured by Graviti Pharmaceuticals Pvt. Ltd., India. Includes storage instructions, prescription status, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.